Pharmaniaga confident of securing govt contracts based on past performance


In September, Finance Minister Lim Guan Eng(pic) had announced that Putrajaya would review its existing contract with Pharmaniaga, and expressed concerns about the effects of an alleged drug provision monopoly on public healthcare cost. Analysts said investors had sold down the stock because they did not like uncertainty, even though there are chances that the company may win a contract even in an open tender system

PETALING JAYA: Pharmaniaga Bhd has voiced its confidence in securing contracts from the Health Ministry even as its share price tanked 11.6% following the termination of its concession to distribute medicine in the country.

The company will see its exclusive concession to distribute drugs and medical supplies for the Health Ministry ending from Nov 30, with an open tender system being introduced.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Ringgit soft as US$ remains elevated
Product innovation drives sales of local plastic packaging
Bursa's rally continues ahead of economic releases
Trading ideas: MyEG, Axis REIT, Mah Sing, Capital A, Hibiscus, Chin Hin, Carlsberg, I-Bhd
Booming eCommerce bolsters consumption
Chemical recycling to reduce plastic waste
Sasbadi reports record high quarterly revenue on robust sales
LME takes aim at traders’ Russian metal games with new rules
Helping more city-state F&B businesses to expand overseas
Funds raised by Singapore’s tech startups up 59% in 2023

Others Also Read